The analyst further reasoned that the high ocular toxicity rates, including keratopathy and visual acuity changes, are ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

Arbitrators cleared the way for the long-delayed $53 billion acquisition after Exxon tried to pre-empt the deal. 3M raised its full-year earnings outlook after beating expectations in the second ...